Glutamate: biomarker evidence

Glutamate appears in 1 entry of the OSMF biomarker atlas, covering Migraine. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Migraine

Where Glutamate is reported

ConditionDirectionCompared againstAssociated symptomsSource
Migraine↑ elevatedhealthy controls (implied by 'migraine patients')migraineD'Andrea et al. 2010

Frequently asked questions

In which conditions is Glutamate altered?

In the OSMF atlas Glutamate is reported in Migraine. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Glutamate?

The atlas entries for Glutamate do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Glutamate result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Glutamate across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/glutamate.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.